Financial GuidanceAlignment Healthcare lowered the midpoint of fiscal year 2024 EBITDA guidance from breakeven to ($3m).
Market CompetitionThe MA market is likely set to benefit the most among all end-markets in our coverage universe from a Trump administration and GOP sweep through Congress, marking a seismic shift from the current severe policy austerity.
Profitability ChallengesDespite strong growth, Alignment Healthcare faces challenges in achieving profitability, as indicated by the lowered 2024 EBITDA guidance.